Protalix BioTherapeutics Statistics
Total Valuation
PLX has a market cap or net worth of $109.06 million. The enterprise value is $79.55 million.
Important Dates
The last earnings date was Friday, May 9, 2025, before market open.
| Earnings Date | May 9, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
PLX has 79.61 million shares outstanding. The number of shares has decreased by -5.05% in one year.
| Current Share Class | 79.61M |
| Shares Outstanding | 79.61M |
| Shares Change (YoY) | -5.05% |
| Shares Change (QoQ) | -26.56% |
| Owned by Insiders (%) | 10.46% |
| Owned by Institutions (%) | 11.06% |
| Float | 60.76M |
Valuation Ratios
The trailing PE ratio is 28.45 and the forward PE ratio is 5.71.
| PE Ratio | 28.45 |
| Forward PE | 5.71 |
| PS Ratio | 1.68 |
| Forward PS | 2.62 |
| PB Ratio | 2.37 |
| P/TBV Ratio | 2.41 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | 20.36 |
| EV / Sales | 1.33 |
| EV / EBITDA | 13.36 |
| EV / EBIT | 17.19 |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 2.49, with a Debt / Equity ratio of 0.12.
| Current Ratio | 2.49 |
| Quick Ratio | 1.62 |
| Debt / Equity | 0.12 |
| Debt / EBITDA | 0.69 |
| Debt / FCF | n/a |
| Interest Coverage | 6.83 |
Financial Efficiency
Return on equity (ROE) is 10.42% and return on invested capital (ROIC) is 5.43%.
| Return on Equity (ROE) | 10.42% |
| Return on Assets (ROA) | 3.53% |
| Return on Invested Capital (ROIC) | 5.43% |
| Return on Capital Employed (ROCE) | 9.34% |
| Revenue Per Employee | $280,582 |
| Profits Per Employee | $18,347 |
| Employee Count | 213 |
| Asset Turnover | 0.73 |
| Inventory Turnover | 1.43 |
Taxes
In the past 12 months, PLX has paid $1.25 million in taxes.
| Income Tax | 1.25M |
| Effective Tax Rate | 24.19% |
Stock Price Statistics
The stock price has increased by +20.18% in the last 52 weeks. The beta is -0.22, so PLX's price volatility has been lower than the market average.
| Beta (5Y) | -0.22 |
| 52-Week Price Change | +20.18% |
| 50-Day Moving Average | 2.10 |
| 200-Day Moving Average | 1.86 |
| Relative Strength Index (RSI) | 27.89 |
| Average Volume (20 Days) | 662,786 |
Short Selling Information
The latest short interest is 956,150, so 1.20% of the outstanding shares have been sold short.
| Short Interest | 956,150 |
| Short Previous Month | 995,483 |
| Short % of Shares Out | 1.20% |
| Short % of Float | 1.57% |
| Short Ratio (days to cover) | 0.76 |
Income Statement
In the last 12 months, PLX had revenue of $59.76 million and earned $3.91 million in profits. Earnings per share was $0.05.
| Revenue | 59.76M |
| Gross Profit | 29.87M |
| Operating Income | 4.63M |
| Pretax Income | 6.77M |
| Net Income | 3.91M |
| EBITDA | 5.96M |
| EBIT | 4.63M |
| Earnings Per Share (EPS) | $0.05 |
Full Income StatementBalance Sheet
The company has $34.74 million in cash and $5.24 million in debt, giving a net cash position of $29.51 million or $0.37 per share.
| Cash & Cash Equivalents | 34.74M |
| Total Debt | 5.24M |
| Net Cash | 29.51M |
| Net Cash Per Share | $0.37 |
| Equity (Book Value) | 45.21M |
| Book Value Per Share | 0.58 |
| Working Capital | 36.19M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$572,000 and capital expenditures -$990,000, giving a free cash flow of -$1.56 million.
| Operating Cash Flow | -572,000 |
| Capital Expenditures | -990,000 |
| Free Cash Flow | -1.56M |
| FCF Per Share | -$0.02 |
Full Cash Flow StatementMargins
Gross margin is 49.97%, with operating and profit margins of 7.74% and 6.54%.
| Gross Margin | 49.97% |
| Operating Margin | 7.74% |
| Pretax Margin | 8.63% |
| Profit Margin | 6.54% |
| EBITDA Margin | 9.97% |
| EBIT Margin | 7.74% |
| FCF Margin | n/a |
Dividends & Yields
PLX does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | 5.05% |
| Shareholder Yield | 5.05% |
| Earnings Yield | 3.58% |
| FCF Yield | -1.43% |
Analyst Forecast
The average price target for PLX is $15.00, which is 994.89% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $15.00 |
| Price Target Difference | 994.89% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 1 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | |
| Graham Upside | |
Stock Splits
The last stock split was on December 20, 2019. It was a reverse split with a ratio of 0.1:1.
| Last Split Date | Dec 20, 2019 |
| Split Type | Reverse |
| Split Ratio | 0.1:1 |
Scores
PLX has an Altman Z-Score of -3.32 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -3.32 |
| Piotroski F-Score | 3 |